Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs
The Journal of Clinical Psychiatry · 25.05.2026 · 87 (2)
DOI: 10.4088/jcp.26f16467 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 25.05.2026. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India; Department of…. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Sleep, Sleep Initiation and Maintenance Disorders.
Themen: Schlaf
Abstract (Originalsprache)
Sleep is an important biological function. This article considers practical matters related to the prescription of sedative-hypnotic drugs to patients with insomnia. This article also presents practical suggestions for the management of excessive sedation in patients who need pharmacologic treatments with sedating adverse effects when dose reduction is not an option. Issues examined include the choice of drug for sleep-onset insomnia and for sleep-maintenance insomnia; the choice of drug for insomnia in patients with psychiatric disorders; sedative-hypnotic dosing in contexts such as perturbation of multiple neurotransmitter systems; metabolic drug interactions with sedative-hypnotic drugs; gastrointestinal absorption of hypnotic drugs and time to onset of drowsiness; the effect of food on absorption and time to onset of drowsiness; the effect of glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs on absorption and time to onset of drowsiness; the importance of half-life for the duration of action of the sedative-hypnotic drug; strategies to address oversedation with sedating psychotropic drugs; treating insomnia with classical monoamine oxidase inhibitors, especially tranylcypromine; optimization of sedative-hypnotic therapy; provision of patient guidance; and related matters. Readers are also reminded that sleep hygiene and cognitive-behavioral approaches should routinely be combined with sedative-hypnotic drug therapy to optimize insomnia care and improve treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India; Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Educa…
- Corresponding Author: Chittaranjan Andrade, MD, Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore 560029, India (andradec@gmail.com).
Zitieren
APA
Andrade, C. (2026). Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.26f16467
Vancouver
Andrade C. Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.26f16467
BibTeX
@article{Andrade2026,
author = {Andrade, Chittaranjan},
title = {Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
volume = {87},
number = {2},
doi = {10.4088/jcp.26f16467}
}
EUVIMED